NASDAQ:CLSD
Delisted

Clearside Biomedical Stock Predictions

etoro logo Buy CLSD
*Your capital is at risk
$0.410
+0 (+0%)
At Close: Mar 13, 2026
Currently predicting for Mon, 8 Jun 2026

CLSD Prediction Chart

CLSD Predictions History

Latest community submissions for CLSD.
Predictor Target Session Target Price Result Direction Accuracy Score
Alan Alan Pro @Alan.115878
Mar 23, 2020 $1.49 +8.76% $1.37 X 91.24% 1
JS JS Pro
Feb 10, 2020 $3.26 +12.41% $2.90 X 87.59% 0
Alan Alan Pro @Alan.115878
Feb 10, 2020 $3.30 +13.79% $2.90 X 86.21% 0
やっちゃん やっちゃん @E38284E381A3E381A1E38283E38293.132791
Jan 21, 2020 Bearish $2.85 X 0
2poJeff 2poJeff Pro
Jan 21, 2020 $2.77 -2.81% $2.85 X 97.19% 0
JS JS Pro
Jan 21, 2020 $3.05 +7.02% $2.85 X 92.98% 1
Alan Alan Pro @Alan.115878
Jan 21, 2020 $3.06 +7.37% $2.85 X 92.63% 1
Nators Nators Amateur
Jan 21, 2020 $2.97 +4.21% $2.85 X 95.79% 1
Michael Tyler Michael Tyler Merchant @MichaelTyler.131297
Jan 21, 2020 $2.98 +4.56% $2.85 X 95.44% 1
A Izzy A Izzy @AIzzy.125367
Jan 21, 2020 $2.48 -12.98% $2.85 X 87.02% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CLSD with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CLEARSIDE BIOMEDICAL, INC
Clearside BioMedical
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an i...
GOLDEN STAR
Ticker Change Signal Date

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE